The Rothschild Foundation recognized in the national system

6/16/2017 - Health

On the occasion of the renewal of labels of rare disease centers for the period of 2017-2022, the Rothschild Foundation is recognized for the first time in the national system

Contacts
The Edmond de Rothschild Foundations
Phone +33 (0)142564646
info@edrfoundations.org

The Rothschild Foundation makes a notable entry into the national labeling system for rare disease centers

On the occasion of the renewal of labels of rare disease centers for the period of 2017-2022, the Rothschild Foundation is recognized for the first time in the national system, with no less than 8 first round winners and one candidate still in progress for the second round:

  • Rare disorders in ophthalmological genetics, Prof. Eric Gabison, Department of Ophthalmology;
  • Neuroretinal Rare Diseases, Dr. Yannick Le Mer, Dr. Catherine Vignal, Department of Ophthalmology;
  • Rare Diseases in Pediatric Ophthalmology, Dr Georges Caputo, Pr Eric Gabison, Department of Ophthalmology;
  • Keratoconus, Prof. Eric Gabison, Department of Ophthalmology;
  • Rare Epilepsies, Dr. Georg Dorfmüller, Department of Pediatric Neurosurgery;
  • Neurogenetic Diseases and Abnormal Movements, Dr. Nathalie Dorison, Pediatric Neurosurgery Department;
  • Rare systemic autoimmune diseases, Dr. Jean-Marc Ziza, Institute of Internal Medicine, Eastern Paris;
  • Rare diseases with psychiatric expression, Sylvie Chokron, neurovision - neurocognition unit;
  • Rare neurological vascular anomalies, Dr. Michel Piotin, interventional neuroradiology department (in progress).

Even though the Ministry of Health decided to restrict the number of expert centers to re-evaluate the existing system, the Foundation succeeded in obtaining a very significant number of labels, placing it in the top private health care institutions in this area.

Congratulations to all the teams that have made this success possible, which reflects the recognition of the Foundation's medical and scientific community.

This increased visibility in the management of rare diseases is fully in line with the strategy of positioning our institution in hyper-specialized niches and the hospital-university dynamic. The Foundation thus turns its full commitment to the service of patients in lack of treatment or in situations of diagnostic error.

"Transmitting, Innovating, Engaging", the Foundation is more than ever faithful to its values!


Source